Effects of Fish Oil on Post Ablation Arrhythmias

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Atrial Fibrillation

In brief

To determine if peri-operative treatment with omega-3 fatty acids is associated with a decrease in the incidence of early recurrences of atrial arrhythmias (within 30 days) and an improvement in probability of long-term maintenance of sinus rhythm after radiofrequency catheter ablation for Atrial Fibrillation.

Key facts

Study ID

NCT00791089

Run by

University of Michigan

People needed

12

Starts

2008-11-01

Expected to finish

2011-10-01

Last updated by the study team

2017-09-12

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years and < 70 years old
• Left atrial size <55 mm

You may not qualify if…

• Inability or unwillingness to provide informed consent
• Current therapy with omega-3 fatty acids
• Current therapy with a statin
• Active liver disease
• Significant comorbidity such as end-stage renal disease or cirrhosis
• Valvular prosthesis

Where it is running

• University of Michigan Cardiovascular Center — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.